| 2ASU | B: | CRYSTAL STRUCTURE OF THE BETA-CHAIN OF HGFL/MSP |
| 2BDG | A:; B: | HUMAN KALLIKREIN 4 COMPLEX WITH NICKEL AND P-AMINOBENZAMIDINE |
| 2BDH | A:; B:; C:; D: | HUMAN KALLIKREIN 4 COMPLEX WITH ZINC AND P-AMINOBENZAMIDINE |
| 2BDI | A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:; M:; N:; O:; P: | HUMAN KALLIKREIN 4 COMPLEX WITH COBALT AND P-AMINOBENZAMIDINE |
| 2I6Q | A:443-732 | COMPLEMENT COMPONENT C2A |
| 2I6S | A:443-732 | COMPLEMENT COMPONENT C2A |
| 2ODP | A:443-730 | COMPLEMENT COMPONENT C2A, THE CATALYTIC FRAGMENT OF C3- AND C5-CONVERTASE OF HUMAN COMPLEMENT |
| 2ODQ | A:443-730 | COMPLEMENT COMPONENT C2A, THE CATALYTIC FRAGMENT OF C3- AND C5-CONVERTASE OF HUMAN COMPLEMENT |
| 2OQ5 | A: | CRYSTAL STRUCTURE OF DESC1, A NEW MEMBER OF THE TYPE II TRANSMEMBRANE SERINE PROTEINASES FAMILY |
| 2PSX | A: | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 5 IN COMPLEX WITH LEUPEPTIN |
| 2PSY | A: | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 5 IN COMPLEX WITH LEUPEPTIN AND ZINC |
| 2QXG | A:; B: | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH ALA-ALA-PHE-CHLOROMETHYLKETONE |
| 2QXH | A: | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH SUC-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE |
| 2QXI | A: | HIGH RESOLUTION STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH SUC-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE |
| 2QXJ | A: | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH SUC-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE AND COPPER |
| 2QY0 | B:; D: | ACTIVE DIMERIC STRUCTURE OF THE CATALYTIC DOMAIN OF C1R REVEALS ENZYME-PRODUCT LIKE CONTACTS |
| 2ZGC | A: | CRYSTAL STRUCTURE OF ACTIVE HUMAN GRANZYME M |
| 2ZGH | A: | CRYSTAL STRUCTURE OF ACTIVE GRANZYME M BOUND TO ITS PRODUCT |
| 2ZGJ | A: | CRYSTAL STRUCTURE OF D86N-GZMM COMPLEXED WITH ITS OPTIMAL SYNTHESIZED SUBSTRATE |
| 2ZKS | A: | STRUCTURAL INSIGHTS INTO THE PROTEOLYTIC MACHINERY OF APOPTOSIS-INDUCING GRANZYME M |
| 3BSQ | A:; B:; C: | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 PRODUCED AS A SECRETION PROTEIN IN E.COLI |
| 3DFJ | A: | CRYSTAL STRUCTURE OF HUMAN PROSTASIN |
| 3DFL | A: | CRYSTAL STRUCTURE OF HUMAN PROSTASIN COMPLEXED TO 4-GUANIDINOBENZOIC ACID |
| 3E0N | B: | THE X-RAY STRUCTURE OF HUMAN PROSTASIN IN COMPLEX WITH DFFR-CHLOROMETHYL KETONE INHIBITOR |
| 3E0P | B: | THE X-RAY STRUCTURE OF HUMAN PROSTASIN IN COMPLEX WITH A COVALENT BENZOXAZOLE INHIBITOR |
| 3E16 | B: | X-RAY STRUCTURE OF HUMAN PROSTASIN IN COMPLEX WITH BENZOXAZOLE WARHEAD PEPTIDOMIMIC, LYSINE IN P3 |
| 3E1X | B: | THE CRYSTAL STRUCTURE OF APO PROSTASIN AT 1.7 ANGSTROMS RESOLUTION |
| 3FVF | B: | THE CRYSTAL STRUCTURE OF PROSTASIN COMPLEXED WITH CAMOSTAT AT 1.6 ANGSTROMS RESOLUTION |
| 3GOV | B: | CRYSTAL STRUCTURE OF THE CATALYTIC REGION OF HUMAN MASP-1 |
| 3GYL | B: | STRUCTURE OF PROSTASIN AT 1.3 ANGSTROMS RESOLUTION IN COMPLEX WITH A CALCIUM ION. |
| 3GYM | A:; B: | STRUCTURE OF PROSTASIN IN COMPLEX WITH APROTININ |
| 3NUM | A: | SUBSTRATE INDUCED REMODELING OF THE ACTIVE SITE REGULATES HTRA1 ACTIVITY |
| 3TJN | A:; B:; D: | HTRA1 CATALYTIC DOMAIN, APO FORM |
| 3TJO | A:; B:; D: | HTRA1 CATALYTIC DOMAIN, MUTATIONALLY INACTIVATED |
| 4KP0 | A: | CRYSTAL STRUCTURE OF THE HUMAN CHYMASE WITH TJK002 |
| 4NA7 | A: | FACTOR XIA IN COMPLEX WITH THE INHIBITOR 3'-[(2S,4R)-6-CARBAMIMIDOYL-4-METHYL-4-PHENYL-1,2,3,4-TETRAHYDROQUINOLIN-2-YL]-4-CARBAMOYL-5'-[(3-METHYLBUTANOYL)AMINO]BIPHENYL-2-CARBOXYLIC ACID |
| 4NA8 | A: | FACTOR XIA IN COMPLEX WITH THE INHIBITOR 5-AMINOCARBONYL-2-[3-[(2S, 4R)-6-CARBAMIMIDOYL-4-METHYL-4-PHENYL-2,3-DIHYDRO-1H-QUINOLIN-2-YL]PHENYL]BENZOIC ACID |
)
)